## CPAY: Corpay, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 1.3% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($287.58)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Analysts Offer Insights on Technology Companies: Lumentum Holdings (LITE) and Corpay Inc (CPAY)**
- Source: The Globe and Mail | 20251207T130916 | Bullish | Relevance: 92%
-  Analysts from Mizuho Securities have issued bullish sentiments on Lumentum Holdings (LITE) and Corpay Inc (CPAY). Vijay Rakesh maintained a Buy rating for Lumentum with a $350.00 price target, while Dan Dolev gave Corpay Inc a Buy rating and a $380.00 price target. The reports suggest a "Moderate Buy" consensus for both companies from the broader analyst community.

**2. Analysts Offer Insights on Technology Companies: Lumentum Holdings (LITE) and Corpay Inc (CPAY)**
- Source: The Globe and Mail | 20251207T130852 | Bullish | Relevance: 83%
-  Two technology companies, Lumentum Holdings (LITE) and Corpay Inc (CPAY), recently received bullish sentiments from analysts. Mizuho Securities maintained a Buy rating on Lumentum Holdings with a $350.00 price target, while Corpay Inc also received a Buy rating and a $380.00 price target from Mizuho Securities analyst Dan Dolev.

**3. Analysts Offer Insights on Technology Companies: Lumentum Holdings (LITE) and Corpay Inc (CPAY)**
- Source: The Globe and Mail | 20251207T042339 | Bullish | Relevance: 81%
-  Analysts from Mizuho Securities have issued bullish ratings for Lumentum Holdings (LITE) and Corpay Inc (CPAY). Vijay Rakesh maintained a Buy rating for Lumentum with a $350 price target, while Dan Dolev assigned a Buy rating to Corpay with a $380 price target, also noting Oppenheimer upgraded Corpay to Buy. The technology sector appears to show optimistic sentiment from these analyses.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Oppenheimer | $380 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Oppenheimer | up | Outperform |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 60.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- JPMORGAN CHASE & CO: 12.7% (+93.8%)
- Vanguard Group Inc: 11.7% (+0.7%)
- Blackrock Inc.: 9.0% (+0.3%)
- Orbis Allan Gray Ltd: 5.9% (+7.1%)
- Price (T.Rowe) Assoc: 5.5% (-21.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +1.1% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.90 indicates undervaluation relative to growth. Forward P/E 12.2x attractive for 17% earnings growth. Quality metrics strong (ROE 29%, margin 24%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $21.4B |
| Beta | 0.85 |
| 52W Range | $252.84 - $400.81 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.90 |
| Forward P/E | 12.2 |
| Current P/E | 14.3 |
| YoY Growth | 16.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 0.1% to 1.3% (+1.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.7pp (needs >3.0% for momentum thesis). MRS_5 at 0.6% confirms short-term momentum alignment. Below SMA200 (0.96x), long-term trend not supportive. MACD histogram positive (2.47), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.27% (CS: 68) | Neutral |
| RSI_14 | 61.7 | Neutral |
| MACD Histogram | 2.47 | Bullish |
| vs SMA20 | 1.051x | Above |
| vs SMA50 | 1.069x | Above |
| vs SMA200 | 0.959x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $303.70
- **Stop Loss:** $287.58 (5.3% risk)
- **Target:** $319.82 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 74
- **Position Value:** $22,473.80
- **Portfolio %:** 22.47%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2026-02-04 (Est: $5.93)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.64 | $5.70 | +1.0% |
| 2025Q2 | $5.12 | $5.13 | +0.1% |
| 2025Q1 | $4.51 | $4.51 | -0.1% |
| 2024Q4 | $5.35 | $5.36 | +0.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*